M&A Deal Summary

MediBeacon Acquires Mannheim Pharma & Diagnostics

On June 8, 2016, MediBeacon acquired medical products company Mannheim Pharma & Diagnostics

Acquisition Highlights
  • This is MediBeacon’s 1st transaction in the Medical Products sector.
  • This is MediBeacon’s 1st transaction in Germany.

M&A Deal Summary

Date 2016-06-08
Target Mannheim Pharma & Diagnostics
Sector Medical Products
Buyer(s) MediBeacon
Deal Type Add-on Acquisition

Target

Mannheim Pharma & Diagnostics

Mannheim, Germany
Mannheim Pharma & Diagnostics GmbH is a provider of medical devices for medical schools, academic centers, research institutes and pharmaceutical companies.

Search 215,130 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

MediBeacon

St. Louis, Montana, United States

Category Company
Founded 2012
Sector Medical Products
DESCRIPTION

MediBeacon, Inc. is a provider of biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Germany M&A 1 of 1
Year: 2016 M&A 1 of 1